A biotechnology corporation
Intellectual Property and Process Patent Issues- Implementation of P.L. 108-173, matters related to Medicare and Medicaid Coverage and Reimbursement [Medicare Prescription Drug Savings and Choice Act of 2013,  Medicare Prescription Drug Price Negotiation Act of 2013 H.R. 928/H.R. 1102]; issues relating to Prescription Drug User Fee Act and ASP +6; issues related to comparative effectiveness and follow-on biologics, issues related to FDA repeal of Avastin; issues related to coverage of Lucentis and Avastin; H.R. 4438 - American Research and Competitiveness Act of 2014; Issues related to 340B. Trade related issues. Tax related issues.
CPT - Copyright/Patent/Trademark MMM - Medicare/Medicaid TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FORBES-TATE
777 6th Street NW, 8th Floor, Washington, DC, 20001, US
JEFFREY FORBES ELIZABETH GREER JERRY DRISCOLL JEFFREY FORBES JERRY DRISCOLL ELIZABETH GREER JEFFREY FORBES JERRY DRISCOLL ELIZABETH GREER JEFFREY FORBES JERRY DRISCOLL ELIZABETH GREER